Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury

NCT02027246 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Spinal Cord Injury

Interventions

BIOLOGICAL: Autologous bone marrow mononuclear cell transplantation

Sponsor

Neurogen Brain and Spine Institute